Heather Verry: Diabetes New Zealand CEO on the funding of wearable glucose monitors
Update: 2025-11-25
Description
Thousands of cases of amputation and vision loss could be prevented thanks to diabetes monitoring technology.
Continuous Glucose Monitors, or CGMs, have been funded for Type 1 diabetes since last October.
New data from CGM producer Dexcom finds lifetime use of the devices could prevent up to 70 thousand diabetes-related complications and save the country $50 thousand a day.
Diabetes New Zealand Chief Executive Heather Verry told Mike Hosking funding should be expanded to all diabetes patients.
She says Pharmac is only funding for Type 1, and at $200 a month, these devices are unaffordable for everyone else.
LISTEN ABOVE
See omnystudio.com/listener for privacy information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
